Identification of PDZ ligands by docking-based virtual screening for the development of novel analgesic agents

Abstract : Disrupting the interaction between the PDZ protein, PSD-95, and its target ligands (such as the glutamate NMDA receptor or the serotonin 5-HT2A receptor) was found to reduce hyperalgesia in various models of neuropathic pain. Here, we set out to identify lead molecules which would interact with PSD-95, and hence, would potentially display analgesic activity. We describe the virtual screening of the Asinex and Cambridge databases which together contain almost one million molecules. Using three successive docking filters and visual inspection, we identified three structural classes of molecules and synthesized a potential lead compound from each class. The binding of the molecules with the PDZ domains of PSD-95 was assessed by 1H-15N HSQC NMR experiments. The analgesic activity of the best ligand, quinoline 2, was evaluated in vivo in a model of neuropathic pain and showed promising results.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-00846217
Contributor : Stéphanie Bonnefoy <>
Submitted on : Thursday, July 18, 2013 - 4:48:41 PM
Last modification on : Friday, February 16, 2018 - 9:44:01 AM

Identifiers

  • HAL Id : hal-00846217, version 1

Citation

Naoual Bouzidi, Hemantkumar Deokar, Alexandre Vogrig, Benjamin Boucherle, Isabelle Ripoche, et al.. Identification of PDZ ligands by docking-based virtual screening for the development of novel analgesic agents. Bioorganic and Medicinal Chemistry Letters, Elsevier, 2013, 23, pp.2624-2627. ⟨hal-00846217⟩

Share

Metrics

Record views

214